Atomo Diagnostics Limited

AT1

AU0000080327

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. Other stock markets 07:10:53 31/05/2024 BST			5-day change	1st Jan Change
0.03 ^AUD	+7.14%		-3.23%	+36.36%

05-16	Easing US Inflation Boosts Australian Shares to Six-Week High	MT
05-16	Atomo Diagnostics Supports HIV-Self Testing Push of the Australian Federal Government; Shares Surge 19%	MT

Atomo Diagnostics Limited Appoints Constance Carnabuci as Director

April 19, 2020 at 11:26 pm

Atomo Diagnostics Limited announced the appointment of Constance (Connie) Carnabuci as Director, with effect from February 4, 2020.

Latest news about Atomo Diagnostics Limited

Easing US Inflation Boosts Australian Shares to Six-Week High	05-16	MT
Atomo Diagnostics Supports HIV-Self Testing Push of the Australian Federal Government; Shares Surge 19%	05-16	MT
Transcript : Atomo Diagnostics Limited, Q3 2024 Earnings Call, Apr 30, 2024	04-30
Atomo Diagnostics Wins AU$570,000 HIV Self-Tests Order	04-15	MT
Atomo Diagnostics Wins Order to Supply AU$970,000 Worth of HIV Self-Tests	03-06	MT
Transcript : Atomo Diagnostics Limited, H1 2024 Earnings Call, Feb 26, 2024	02-26
Atomo Diagnostics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-25	CI
Transcript : Atomo Diagnostics Limited, Q2 2024 Earnings Call, Jan 30, 2024	01-30
Atomo Diagnostics Limited Announces the Resignation of Curt LaBelle as Non-Executive Director	12-19	CI
Actinogen Medical Names CFO	11-08	MT
Atomo Diagnostics CFO to Step Down	11-07	MT
Atomo Diagnostics Limited Announces the Departure of William Souter as Chief Financial Officer, Effective 13 December 2023	11-06	CI
Transcript : Atomo Diagnostics Limited - Shareholder/Analyst Call	11-01
Transcript : Atomo Diagnostics Limited, Q1 2024 Earnings Call, Oct 26, 2023	26/10/23
Atomo Diagnostics Expands Footprint of HIV Self-Test Kit	20/10/23	MT
Seattle-based startup makes 'beanless coffee' to help combat deforestation	04/10/23	RE
Transcript : Atomo Diagnostics Limited, 2023 Earnings Call, Aug 24, 2023	24/08/23
Atomo Diagnostics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	24/08/23	CI
Atomo Diagnostics Raises AU$2.3 Million Via Placement, Share Purchase Plan	08/08/23	MT
Transcript : Atomo Diagnostics Limited, Q4 2023 Earnings Call, Jul 27, 2023	27/07/23
Atomo Diagnostics Raising AU$4 Million Via Placement, Share Purchase Plan	13/07/23	MT
Atomo Diagnostics Signs Deal to Supply HIV Tests to Europe	14/06/23	MT
Transcript : Atomo Diagnostics Limited - Special Call	01/05/23
Atomo Diagnostics Secures Nearly $2 Million Supply Deal for HIV Self-Test in South Africa	05/04/23	MT
Atomo Diagnostics Secures AU$900,000 HIV Self-Tests Order	28/02/23	MT

Chart Atomo Diagnostics Limited

Duration

Period

More charts

Atomo Diagnostics Limited is an Australia-based medical device company. The Company supplies integrated rapid diagnostic test (RDT) devices to the global diagnostic market. The Companyâs patented devices simplify testing procedures, enhance usability and improve reliability across rapid point-of-care (POC) and at-home testing applications. The Company has commercialized a number of products across international markets and has supply agreements in place for testing applications targeting infectious diseases, including COVID-19, HIV, viral vs bacterial differentiation and female health. Its products include Atomo HIV Self-Test, AtomoRapid HIV (1&2) and ATOMONOW Pregnancy Test. Its Atomo HIV Self-Test is an integrated, blood-based rapid diagnostic test (RDT) for HIV screening, which provides results in 15 minutes. Its AtomoRapid HIV (1&2) integrates multiple test components into the device platform. AtomoRapid HIV (1&2) needs a small drop of blood to give results in 15 minutes.

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
ATOMO DIAGNOSTICS LIMITED	+36.36%	12.73M
THERMO FISHER SCIENTIFIC	+7.01%	217B
DANAHER CORPORATION	+11.01%	190B
INTUITIVE SURGICAL, INC.	+19.20%	143B
BOSTON SCIENTIFIC CORPORATION	+30.79%	111B
SIEMENS HEALTHINEERS AG	+1.48%	64.59B
EDWARDS LIFESCIENCES CORPORATION	+13.95%	52.36B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.16%	48.45B
AGILENT TECHNOLOGIES, INC.	-6.20%	38.03B
GE HEALTHCARE TECHNOLOGIES INC.	+0.91%	35.61B

Other Advanced Medical Equipment & Technology